Clinical Trials Browser

Diabetes Mellitus, Obesity, Endometrial Neoplasms, Overweight

NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05691010 2026-02-04

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Phase EARLY_PHASE1 Recruiting

28 enrolled

Gynecologic

Endometrial Neoplasms

NCT07065552 2026-01-28

Tirzepatide in Obesity-Driven Endometrial Cancer

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

NCT07316361 2026-01-07

GYNORYLAQ™

Phase EARLY_PHASE1 Enrolling by invitation

40 enrolled

Gynecologic

Endometrial Neoplasms

NCT07278986 2025-12-12

CYTALUX ISS

Phase EARLY_PHASE1 Recruiting

10 enrolled

Gynecologic

Endometrial Neoplasms

NCT05320757 2025-06-11

Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients

Phase EARLY_PHASE1 Completed

20 enrolled

Gynecologic

Endometrial Neoplasms

Clinical Trials

A Study of a Weight Loss Intervention in People With Endometrial Cancer

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Tirzepatide in Obesity-Driven Endometrial Cancer

GYNORYLAQ™

CYTALUX ISS

Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients